Correlation Between Summit Therapeutics and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and Spero Therapeutics, you can compare the effects of market volatilities on Summit Therapeutics and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Spero Therapeutics.
Diversification Opportunities for Summit Therapeutics and Spero Therapeutics
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Summit and Spero is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Summit Therapeutics and Spero Therapeutics
Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 1.26 times more return on investment than Spero Therapeutics. However, Summit Therapeutics is 1.26 times more volatile than Spero Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 2,150 in Summit Therapeutics PLC on December 2, 2024 and sell it today you would lose (81.00) from holding Summit Therapeutics PLC or give up 3.77% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Summit Therapeutics PLC vs. Spero Therapeutics
Performance |
Timeline |
Summit Therapeutics PLC |
Spero Therapeutics |
Summit Therapeutics and Spero Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Summit Therapeutics and Spero Therapeutics
The main advantage of trading using opposite Summit Therapeutics and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.Summit Therapeutics vs. Nkarta Inc | Summit Therapeutics vs. Cullinan Oncology LLC | Summit Therapeutics vs. Kezar Life Sciences | Summit Therapeutics vs. Kronos Bio |
Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |